Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 383-388

  Varella, Ivana S ^a   Canti, Ivete C T ^a   Santos, Breno R ^a   Coppini, Angela Z ^a   Argondizzo, Luciana C ^a   Tonin, Carina ^a   Wagner, Mário B ^b  

^a HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Congenital toxoplasmosis; Pregnancy; Toxoplasmosis

Indexed keywords

TOXOPLASMA GONDII;

EID: 65549107076     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200037     Document Type: Article

References (41)

1. Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Ades AE 1996. Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 116: 347-351.
2. Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, De Souza CB, Maciel LM 2005. Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect 133: 485-491.
3. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT 2000. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. Bmj 321: 142-147.
4. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833.
5. Evengard B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Tear-Fahnehjelm K, Forsgren M, Gilbert R, Malm G 2001. Low incidence of Toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 127: 121-127.
6. Figueiro-Filho EA, Senefonte FR, Lopes AH, de Morais OO, Souza Junior VG, Maia TL, Duarte G 2007. Freqüência das infecções pelo HIV-1, rubéola, sífilis, toxoplasmose, citomegalovírus, herpes simples, hepatite B, hepatite C, doença de Chagas e HTLV I/II em gestantes do Estado de Mato Grosso do Sul. Rev Soc Bras Med Trop 40: 181-187.
7. Foulon W, Naessens A, Ho-Yen D 2000. Prevention of congenital toxoplasmosis. J Perinat Med 28: 337-345.
8. Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ 1988. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 72: 363-366.
9. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A 1999. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180: 410-415.
10. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M, Kortbeek T, Peyron F, Pollak A, Petersen E 2001. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect 127: 113-120.
11. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD 1995. Incidence of acute symptomatic Toxoplasma retinochoroiditis in South London according to country of birth. Bmj 310: 1037-40.
12. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Junior M, Silveira S, Camargo ME, Nussenblatt RB, Kaslow RA, Belfort Junior R 1992. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 114: 136-144.
13. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R 2005. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 94: 1721-1731.
14. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, Grady GF. 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 330: 1858-1863.
15. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F 1989. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115: 765-769.
16. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, Eng J 1998. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36: 2900-2906.
17. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R 2001. Congenital toxoplasmosis: a review. Obstet Gynecol Surv 56: 296-305.
18. Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J 1996. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol 144: 405-412.
19. Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC, Parise C, Vargas PR, Goldbeck AS, Fiori RM 2007. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol 21: 525-531.
20. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Norgaard-Pedersen B, Petersen E 1999. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353: 1834-1837.
21. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 15: 799-805.
22. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS 2001. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 183: 1248-1253.
23. Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL 2000. Preventing congenital toxoplasmosis. MMWR Recomm Rep 49: 59-68.
24. Mombro M, Perathoner C, Leone A, Nicocia M, Moiraghi Ruggenini A, Zotti C, Lievre MA, Fabris C 1995. Congenital toxoplasmosis: 10-year follow up. Eur J Pediatr 154: 635-639.
25. Montoya JG, Liesenfeld O 2004. Toxoplasmosis. Lancet 363: 1965-1976.
26. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS 2002. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol 40: 2504-2508.
27. Mozzatto L, Procianoy RS 2003. Incidence of congenital toxoplasmosis in Southern Brazil: a prospective study. Rev Inst Med Trop Sao Paulo 45: 147-151.
28. Munoz Batet C, Guardia Llobet C, Juncosa Morros T, Vinas Domenech L, Sierra Soler M, Sanfeliu Sala I, Bosch Mestres J, Dopico Ponte E, Lite Lite J, Matas Andreu L, Juste Sanchez C, Barranco Romeu M 2004. Toxoplasmosis and pregnancy. Multicenter study of 16,362 pregnant women in Barcelona. Med Clin (Barc) 123: 12-16.
29. Naessens A 2003. Screening for toxoplasmosis during pregnancy: the situation in Belgium. Arch Pediatr 10 (Suppl. 1): 18.
30. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon JM, Petersen E, Foulon W 1999. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 135: 714-719.
31. Neto EC, Anele E, Rubim R, Brites A, Schulte J, Becker D, Tuuminen T 2000. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 29: 941-947.
32. Nobrega OT, Karnikowski MG 2005. An estimation of the frequency of gestational toxoplasmosis in the Brazilian Federal District. Rev Soc Bras Med Trop 38: 358-360.
33. Paul M, Petersen E, Szczapa J 2001. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol 39: 1912-1916.
34. Peyron F, Wallon M, Liou C, Garner P 2000. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev CD001684.
35. Remington JS, McLeod R, Thulliez P, Desmonts G 2005. Toxoplasmosis. In JS Remington, JO Klein, Infectious Diseases of the Fetus and Newborn Infant, WB Saunders, Philadelphia, p. 947-1091.
36. Remington JS, Thulliez P, Montoya JG 2004. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42: 941-945.
37. Safadi MA, Berezin EN, Farhat CK, Carvalho ES 2003. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis 7: 325-331.
38. Segundo GR, Silva DA, Mineo JR, Ferreira MS 2004. Congenital toxoplasmosis in Uberlandia, MG, Brazil. J Trop Pediatr 50: 50-53.
39. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C 2006. Cord blood screening for congenital toxoplasmosis in Northwestern Switzerland, 1982-1999. Pediatr Infect Dis J 25: 123-128.
40. Thiebaut R, Leproust S, Chene G, Gilbert R 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369: 115-122.
41. Varella IS, Wagner MB, Darela AC, Nunes LM, Muller RW 2003. Prevalência de soropositividade para toxoplasmose em gestantes. J Pediatr (Rio J) 79: 69-74.